Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 295, Issue 5, 2008, Pages

  Johnson, Jill R ^a   Pacitto, Stephanie R ^a   Wong, Jonathan ^a   Archer, Elliot W ^a   Eirefelt, Stefan ^b   Miller Larsson, Anna ^b   Jordana, Manel ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b ASTRAZENECA R AND D   (Sweden)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Airway hyperreactivity; Asthma; Pharmacotherapy

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BUDESONIDE PLUS FORMOTEROL; COLLAGEN; HOUSE DUST ALLERGEN; LACTOSE;

AEROSOL; AIRWAY; AIRWAY RESISTANCE; ALLERGENICITY; ALLERGIC ASTHMA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DERMATOPHAGOIDES; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; DRY POWDER; HISTOPATHOLOGY; LONG TERM EXPOSURE; LUNG FUNCTION; METERED DOSE INHALER; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION;

ACTINS; ALLERGENS; ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; BUDESONIDE; COLLAGEN; DRUG THERAPY, COMBINATION; EPITHELIAL CELLS; EPITHELIUM; ETHANOLAMINES; FEMALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; MUCUS; PNEUMONIA; PYROGLYPHIDAE; RESPIRATORY TRACT DISEASES;

EID: 57049183711     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90229.2008     Document Type: Article

References (41)

1. Bateman ED, Bantje TA, Joao Gomes M, Toumbis MG, Huber RM, Naya I, Eliraz A. Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma. Am J Respir Med 2: 275-281, 2003.
2. Boulet LP, Turcotte H, Laviolette M, Naud F, Bernier MC, Martel S, Chakir J. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med 162: 1308-1313, 2000.
3. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola Asthma AM. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161: 1720-1745, 2000.
4. Burke CM, Sreenan S, Pathmakanthan S, Patterson J, Schmekel B, Poulter LW. Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study. Thorax 51: 993-999, 1996.
5. Chakir J, Laviolette M, Boutet M, Laliberte R, Dube J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 75: 735-744, 1996.
6. Cho JY, Miller M, McElwain K, McElwain S, Broide DH. Combination of corticosteroid therapy and allergen avoidance reverses allergen-induced airway remodeling in mice. J Allergy Clin Immunol 116: 1116-1122, 2005.
7. de Baets FM, Goeteyn M, Kerrebijn KF. The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children. Am Rev Respir Dis 142: 581-586, 1990.
8. Ewart SL, Mitzner W, DiSilvestre DA, Meyers DA, Levitt RC. Airway hyperresponsiveness to acetylcholine: segregation analysis and evidence for linkage to murine chromosome 6. Am J Respir Cell Mol Biol 14: 487-495, 1996.
9. Faul JL, Demers EA, Burke CM, Poulter LW. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma. Chest 121: 1414-1420, 2002.
10. Fish JE, Peters SP. Airway remodeling and persistent airway obstruction in asthma. J Allergy Clin Immunol 104: 509-516, 1999.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 344: 219-224, 1994.
12. Grootendorst DC, Dahlen SE, Van Den Bos JW, Duiverman EJ, Veselic-Charvat M, Vrijlandt EJ, O'Sullivan S, Kumlin M, Sterk PJ, Roldaan AC. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy 31: 400-408, 2001.
13. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 325: 388-392, 1991.
14. Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Hosaka K, Isogai S. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 28: 568-577, 1998.
15. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164: S28-S38, 2001.
16. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 145: 890-899, 1992.
17. Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Respirology 11: 276-286, 2006.
18. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ, Gutierrez-Ramos JC, Ellis R, Inman MD, Jordana M. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 169: 378 -385, 2004.
19. Kips JC, Pauwels RA. Airway wall remodelling: does it occur and what does it mean? Clin Exp Allergy 29: 1457-1466, 1999.
20. Leigh R, Ellis R, Wattie J, Southam DS, De Hoogh M, Gauldie J, O'Byrne PM, Inman MD. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 27: 526-535, 2002.
21. McMahon TA, Brain JD, Lemott S. Species Differences in Aerosol Deposition. Oxford, UK: Pergamon, 1977.
22. McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 34: 497-507, 2004.
23. Miller M, Cho JY, McElwain K, McElwain S, Shim JY, Manni M, Baek JS, Broide DH. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am J Physiol Lung Cell Mol Physiol 290: L162-L169, 2006.
24. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164: 1392-1397, 2001.
25. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, Testi R, Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 155: 1864-1871, 1997.
26. Papaioannou VE, Fox JG. Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci 43: 189-192, 1993.
27. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337: 1405-1411, 1997.
28. Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 31: 626-632, 2004.
29. Pohunek P, Kuna P, Jorup C, De Boeck K. Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. Pediatr Allergy Immunol 17: 458-465, 2006.
30. Raabe OG, Al-Bayati MA, Teague SV, Rasolt A. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Inhaled Particles IV. Ann Occup Hyg 32: 53-63, 1988.
31. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159: 1043-1051, 1999.
32. Stampfli MR, Wiley RE, Neigh GS, Gajewska BU, Lei XF, Snider DP, Xing Z, Jordana M. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J Clin Invest 102: 1704-1714, 1998.
33. Swirski FK, Sajic D, Robbins CS, Gajewska BU, Jordana M, Stampfli MR. Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J Immunol 169: 3499 -3506, 2002.
34. Tanaka H, Masuda T, Tokuoka S, Takahashi Y, Komai M, Nagao K, Nagai H. Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling. Inflamm Res 51: 307-316, 2002.
35. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A, Jordan SE, Herdman MJ, Jhalli N, Duddle JM, Hamilton SA. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 150: 17-22, 1994.
36. Ward C, Johns DP, Bish R, Pais M, Reid DW, Ingram C, Feltis B, Walters EH. Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma. Am J Respir Crit Care Med 164: 1718-1721, 2001.
37. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57: 309-316, 2002.
38. Wiley RE, Cwiartka M, Alvarez D, Mackenzie DC, Johnson JR, Goncharova S, Lundblad L, Jordana M. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J Immunol 172: 4995-5005, 2004.
39. Wilson JW, Bamford TL. Assessing the evidence for remodelling of the airway in asthma. Pulm Pharmacol Ther 14: 229-247, 2001.
40. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153: 1481-1488, 1996.
41. Zitt MJ. Advances in inhaled corticosteroid pharmacology. Allergy Asthma Proc 28: 114-124, 2007.